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Growing evidence indicates that PPARγ agonists, including rosiglitazone (RSG), induce adipose mitochondrial biogenesis. By
systematically analyzing mitochondrial gene expression in two common murine adipocyte models, the current study aimed to
further establish the direct role of RSG and capture temporal changes in gene transcription. Microarray proﬁling revealed that
in fully diﬀerentiated 3T3-L1 and C3H/10T1/2 adipocytes treated with RSG or DMSO vehicle for 1, 2, 4, 7, 24, and 48hrs, RSG
overwhelmingly increased mitochondrial gene transcripts time dependently. The timing of the increases was consistent with the
cascade of organelle biogenesis, that is, initiated by induction of transcription factor(s), followed by increases in the biosynthesis
machinery, and then by increases in functional components. The transcriptional increases were further validated by increased
mitochondrialstaining,citrate synthaseactivity, and O2 consumption,and were foundtobeassociated withincreased adiponectin
secretion. The work provided further insight on the mechanism of PPARγ-induced mitochondrial biogenesis in diﬀerentiated
adipocytes.
1.Introduction
Peroxisomal proliferators-activated receptor (PPARγ)a g o -
nists, including rosiglitazone (RSG), are eﬀective in improv-
ing insulin sensitivity in vivo. Several mechanisms have been
established underlying the beneﬁcial eﬀects of PPARγ acti-
vation, including (1) induction of adipogenesis, sequestering
lipids in adipose tissues and away from the liver and muscle,
(2) regulation of adipokine release, inﬂuencing the functions
of other organs through regulating adiponectin and other
adipokine production, and (3) modulation of inﬂammation,
mitigating inﬂammatory responses in adipose tissue and
other organs [1–3].
Emerging evidence supports yet another mechanism—
PPARγ activation also induces mitochondrial biogenesis and
ameliorates the impaired mitochondrial function in adipose
tissues in type 2 diabetes mellitus (T2DM) patients and
rodent models, demonstrated in others’ and our studies [4–
7].However,theinvivoobservationscouldbeduetoanindi-
rect eﬀect, resulting from normalization of hyperglycemia,
changesinadiposeinﬂammation,andsoforth,wherePPARγ
activationhasbeenshowntoplayarole[3].Additionally,the
ongoing adipogenesis from preadipocytes, with which mito-
chondrial biogenesis is associated [8], could have accounted
for the increased expression of mitochondrial genes in the
adipose tissue consisted of a variety of cell types.2 PPAR Research
While a growing number of studies are supporting the
direct role of PPARγ activation on mitochondrial biogenesis
[8–11], the cascade of changes associated with this process
has not been characterized. The present study examined
the temporal regulation of the transcription of virtually all
known nucleus-encoded genes involved in mitochondrial
function and biogenesis in diﬀerentiated murine adipocytes
using gene expression proﬁling. Two murine cell types were
used, 3T3-L1 and C3H/10T1/2 adipocytes. Both are widely
accepted models for adipocyte research, but 3T3-L1 cells
are considered as preadipocytes committed to adipocyte
diﬀerentiation [12, 13], whereas C3H/10T1/2 are multi-
potent cells capable of diﬀerentiating into myoblasts and
other cell types [14]. The transcriptional changes in the two
adipocyte types were further validated by quantitative real-
time RT-PCR (QRT-PCR), mitochondrial staining, citrate
synthase activity and O2 consumption. The work provided
unequivocal evidence for the direct role of RSG, and insight
on the mechanism of adipose mitochondrial biogenesis.
2.MaterialsandMethods
2.1. Cell Culture and Adipocyte Diﬀerentiation. Murine 3T3-
L1 preadipocytes and C3H/10T1/2 cells were purchased
from American Type Culture Collection (Manassas, VA)
and maintained separately in complete medium consisting
of DMEM (Invitrogen, Carlsbad, CA) containing 10% fetal
bovine serum (FBS; Invitrogen). All cultures were incubated
at 37◦C in a humidiﬁed incubator containing 5% CO2 and
95% air.
For diﬀerentiation, both cell types were plated in Costar
plates (Corning, Lowell, MA) precoated with 0.2% gelatin
(Sigma, St. Louis, MO) in phosphate-buﬀered saline (PBS).
3T3-L1 preadipocytes were diﬀerentiated using a protocol
similar to those described previously that included a PPARγ
agonist to ensure consistent diﬀerentiation [15, 16]. Brieﬂy,
cells were plated at 63,000cells/cm2 and allowed to grow
3 days. The cells were then incubated with complete
medium containing insulin (Invitrogen; 0.8μM), 3-isobutyl-
1-methylxanthine (Sigma; 0.5mM), dexamethasone (Sigma;
0.25μM), and RSG (GlaxoSmithKline, Research Triangle
Park, NC, 100nM) for 2 days followed by complete medium
containing insulin (0.8μM) for 2 days, and complete
medium alone for 3 more days.
C3H/10T1/2 cells were plated at 1.26 × 105 cells/cm2
and allowed to grow 24hrs in complete medium to reach
conﬂuence. Cells were then diﬀerentiated in DMEM/F12
(Invitrogen) containing 10% FBS, RSG (10μM), and insulin
(1μM) for 6 days [17].
2.2. Adipocyte Treatments. To avoid desensitizing eﬀects
from RSG, insulin, and serum factors, prior to treat-
ment, all diﬀerentiated murine adipocytes were incubated
for 24hrs in a washout medium, that is, DMEM/F12
medium containing 1% essential fatty acid-free bovine
serumalbumin (BSA,Sigma). Preliminary data indicated the
24hr incubation did not change cell morphology or lipid
content (Figure 1 of the Supplementary Material available
online at doi: 10.1155/2011/179454), or decrease the mRNA
levels of adipocyte markers aP2 (Fabp4) and adiponectin
(Adipoq), or increase of preadipocyte/ﬁbroblast marker
platelet-derived growth factor receptor B (Pdgfrb) [18]
(Tables 1(a) and 1(b) of the Supplementary Material), while
optimally increasing the response to rosiglitazone using
PDK4 and PCK1 as sentinel genes (Supplemental Table 1(c)
of the Supplementary Material). For microarray analysis,
adipocytes in 6-well plates were treated with RSG (1μM) [8]
orvehicle,dimethylsulfoxide(DMSO,Sigma)inthewashout
m e d i u mf o r1 ,2 ,4 ,7 ,2 4 ,a n d4 8 h r s .T oe n s u r ee n o u g h
RNA yield, two wells in a plate were used for each treatment
at each time point, and cells from both wells were pooled
at harvest. There were 3 replicates (diﬀerentiated from 3
diﬀerent batches) in each condition for each cell type.
2.3. Microarray Analysis. Adipocytes were lysed using QIA-
GEN (Qiagen Inc., Valencia, CA) lysis buﬀer. The cell
lysate samples were transferred to QIAGEN RNeasy Mini
columns mounted on a vacuum manifold. RNA isolation,
DNase I treatment, reverse transcription, and cRNA syn-
thesis, labeling, and hybridization with Genechips mouse
genome 430a array containing 14,000 well-characterized
mouse genes (Aﬀymetrix Microarray Suite; Aﬀymetrix,
Santa Clara, CA) were conducted following the standard
Aﬀymetrix protocol as previously described [7]. To avoid
batch eﬀects, the RNA samples (5μgf r o me a c ht r e a t m e n t
condition) were randomized before cRNA synthesis, and
the cRNA samples were rerandomized before hybridiza-
tion. Array intensity data were captured by the GeneChip
Computer Operating System using the algorithm (MAS
5.0; Aﬀymetrix). All data have been deposited by MIAME
standards and will be available through Gene Expres-
sion Omnibus (http://www.ncbi.nlm.nih.gov/gds; Accession
number GSE14810).
2.4. QRT-PCR. Adipocyte RNA was subject to QRT-PCR
as previously described [7]. Cidea, Lpl, Fabp4, and Cpt1b
primer/probes were ordered through Applied Biosystems
(Carlsbad, CA). The sequences of the rest of the genes were
shown in Table 2 of the Supplementary Material, and when
possible, all primer/probes were designed to span intron
regions to avoid ampliﬁcation of genomic DNA. The relative
RNA abundance of the target genes was normalized to the
housekeeping gene 36B4 (Arbp) and expressed as delta delta
CT (equivalent to fold change transformed by Log2).
2.5. Oil Red O Staining. Diﬀerentiated adipocytes were
washed with PBS, ﬁxed in 10% neutral buﬀered formalin
(Sigma), and stained (25 minutes) with Oil Red O (Sigma)
saturatedinisopropanol-watersolution(70:30,v/v).Images
of stained cells were immediately captured with a SPOT RT
Slider camera (Sterling Heights, MI) mounted on a Leica
DMIRE2 microscope.
2.6. Mitochondrial Staining and Quantiﬁcation. Adipocytes
in96-wellblackPackardViewPlates(PerkinElmer,Waltham,
MA) were treated with RSG (1μM) or DMSO for 24 andPPAR Research 3
48hrs and stained (45min, 37◦C) with Mito Tracker Red
CMXRos (Invitrogen; 0.9μM) in the complete medium
containing Hoechst (Sigma; 1μg/mL). For quantiﬁcation,
plates were processed on a Cellomics ArrayScan HCS Reader
using a 20X objective system detecting nuclear ﬂuorescence
via a 365(50)/535(45) ﬁlter set and via a [535(35)/590(35)
ﬁlter set for Mito Tracker Red ﬂuorescence. The Cellomics
“Spot Detector” BioApplication was used to derive data
from images collected. The application was programmed to
manage the collection of data from a minimum of 1000
cytoplasmic objects as determined by nuclear ﬂuorescence
and subsequent segmentation provided by the software.
Areas of Mito Tracker Red staining were segmented by the
proprietary application to eﬀectively threshold these areas as
“spots” with gating input relative to size and intensity. The
resulting spot objects were analyzed to produce well-based
values of “mean total spot intensity per cell” per well. The
data were averaged from 8 replicate wells for each treatment
a n de x p r e s s e da sp e r c e n t a g eo fD M S Oe ﬀect.
2.7. Citrate Synthase Activity. After treatment with RSG
(1μM) or DMSO for 24 and 48hrs, adipocytes in 24-well
plates were lysed directly in CelLytic MT Cell Lysis Reagent
(Sigma; 400μL), and citrate synthase activity and protein
concentrations in the lysate were measured as previously
described [7]. The activity was expressed as μmol·min−1·g
protein−1.
2.8. O2 Consumption. 3T3-L1 adipocytes diﬀerentiated in
96-well plates were treated for 48hrs with RSG at 1μMo r
serially diluted concentrations indicated in the Figure Leg-
ends. The cells were then washed, trypsinized, resuspended
in complete medium, and transferred to 96-well BD Oxygen
Biosensor System plates (BD Biosciences, Franklin Lakes,
NJ). The cell suspension was sealed from air with mineral
oil (Sigma) and incubated at 37◦C. Consumption of O2
by adipocytes was associated with increased ﬂuorescence
released by the Biosensor dye coated at the bottom of the
wells. At 0, 2, 4, 6, 8, 10, and 12hrs, the raw ﬂuorescence
was measured using a ﬂuorescent microplate reader Analyst
HT (Molecular Devices, Sunnyvale, CA) with excitation and
emission wavelengths of 485 and 620nm, respectively. The
data were expressed as raw ﬂuorescent unit or percent of
DMSO-treated, as indicated in Results.
2.9. Adiponectin Measurement. Media from 3T3-L1 adipo-
cytes treated with RSG (1μM )o rD M S Of o r1 ,2 ,4 ,7 ,
24, and 48hrs were collected and diluted by 100-fold,
and adiponectin concentration was determined using a
Quantikine Mouse Adiponectin/Acrp30 kit (R&D Systems,
Minneapolis, MN) following manufacturer’s instruction.
2.10. Statistical Analysis. Microarray data analysis was car-
ried out as previously described [7]. Brieﬂy, probe sets
with intensity values ≥19.9, representing the 95 percentile
of the built-in Aﬀymetrix negative control probe sets for
all the chips, were considered present. Probe set intensity
values were log10-transformed and analyzed using ANOVA.
P<0.05 and a 1.2-fold cutoﬀ for mean fold changes were
used to select genes with a signiﬁcant change [7, 10]. The
relative mRNA abundance from QRT-PCR, mitochondrial
staining area, citrate synthase activity, measurement of O2
consumption,andadiponectinconcentrationwerepresented
asmean ±SEintheﬁgures.Allcomparisonsweredoneusing
ANOVA,andP<0.05wasconsideredstatisticallysigniﬁcant.
3. Results
3.1. Gain of Adipocyte Morphology and Increase in Dif-
ferentiation Marker mRNA after Adipocyte Diﬀerentiation.
At the end of diﬀerentiation, >95% of 3T3-L1 and
C3H/10T1/2 adipocytes contained Oil Red O-stained lipid
droplets (Figure 1(a)). The diﬀerentiation was further con-
ﬁrmed, using QRT-PCR, by dramatic increase in mRNA
levels of Adipoq, Fabp4, lipoprotein lipase (Lpl), and
stearoyl-Coenzyme A desaturase 1 (Scd1) (Figure 1(b)),
and decrease in preadipocyte/ﬁbroblast marker Pdgfrb
(Figure 1(b), insets).
Diﬀerentiated 3T3-L1 adipocytes are white adipocytes
[8], and C3H/10T1/2 adipocytes have some characteristics
of brown adipocytes [19], but are generally considered white
adipocytes[20].Consistentwiththis,wefound,comparedto
3T3-L1, C3H/10T1/2 adipocytes had higher levels of brown
adipocyte markers uncoupling protein 1 (Ucp1) and cell
death-inducing DFFA-like eﬀector A (Cidea) mRNA, respec-
tively (Figure 2 of the Supplementary Material). However,
the levels of other brown adipocyte markers, such as type 2
deiodinase and PGC-1α [20] were similar between the two
cell types (Table 3 of the Supplementary Material).
3.2. RSG Increased Gene Transcripts Encoding Proteins Reg-
ulating Mitochondrial Energy Metabolism in Diﬀerentiated
3T3-L1 and C3H/10T1/2 Adipocytes. Of the 22,626 probe
sets on Aﬀymetrix mouse chip 430a, 268 were previ-
ously [7] identiﬁed to represent genes encoding proteins
localized to mitochondria and related to mitochondrial
energy metabolism. These proteins include those involved in
fatty acid oxidation (FAO), tricarboxylic acid cycle (TCA),
oxidative phosphorylation pathway (OXPHOS), ATP/ADP
shuttles, energy uncoupling proteins (UCP), and voltage-
dependent anion channels (VDAC) responsible for the
translocation of ATP, ADP, and other metabolites across the
mitochondrial outer membrane.
As shown in Figure 2 and Table 4 of the Supplementary
Material, in both diﬀerentiated 3T3-L1 and C3H/10T1/2
adipocytes, there was a time-dependent increase in the
number of energy metabolism genes induced by RSG. At
1hr, pyruvate dehydrogenase kinase 4 (PDK4) was the only
gene in 3T3-L1 and one of the 2 in C3H/10T1/2 adipocytes
signiﬁcantly induced by RSG. At 2hr, there were a few
more genes induced by RSG, and among them shared by
both cell types were PDK4, enoyl-Coenzyme A hydratase/3-
hydroxyacyl Coenzyme A dehydrogenase (Ehhadh; an indis-
pensable com-ponent of the FAO enzymes [21]), carni-
tine acetyltransferase (Crat), which modulates the acetyl-
CoA/CoA ratio favoring FAO [22], and acyl-CoA synthetase4 PPAR Research
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Figure 1: Phenotypic and molecular characterization of 3T3-L1 and C3H/10T1/2 adipocytes after diﬀerentiation. Diﬀerentiated 3T3-L1
and C3H/10T1/2 adipocytes were stained with Oil Red O ((a) Magniﬁcation = 200x). Alternatively, QRT-PCR was performed using RNA
extracted from cells prior to and after diﬀerentiation (b). Relative mRNA levels of adipocyte markers Adipoq, Fabp4, Lpl, and Scd1, and
preadipocyte/ﬁbroblastmarkerPdgfrb(insetin(b))indiﬀerentiatedcellswerecomparedtothoseinpreadipocytes.TheQRT-PCRdatawere
expressed as –ΔΔCt, equivalent to log2-transformed fold changes. All numerical data were expressed as mean ± S.E. ∗P<0.05 compared to
the respective preadipocytes.
long-chain family member 1 (Acsl1), a PPARα target impli-
cated in providing FA for beta-oxidation and triglyceride
synthesis [23, 24].
The largest increase in the number of RSG-induced
genes occurred at 24hrs (70% and 63% of the 268 probe
sets for 3T3-L1 and C3H/10T1/2 adipocytes, resp.), and
most genes remained induced at 48hrs (66% and 57%,
resp.). Among them were those encoding key enzymes or
subunits of enzymes regulating the control points [21]i n
the TCA cycle, namely, pyruvate dehydrogenase complex
(PDC), isocitrate dehydrogenase 3, and α-glutarate dehydro-
genase, those encoding electron transporters in OXPHOS
including cytochrome c and cytochrome c1, and the enzyme
controllingtherateofFAO,carnitinepalmitoyltransferase1B
(CPT1B), as well as other components of the FAO enzymes.
Ucp1 transcription was not changed in 3T3 L1 and
C3H/10T1/2 adipocytes, while Cidea, controlling the protein
levels and activity of AMP-activated protein kinase (AMPK)
[25], was induced by RSG at 24 and/or 48 in both cell types.
Both Ucp2 and Ucp3 were induced by RSG at earlier time
points, that is, 2 or 4hrs in both cell types, and remained
induced through 48hrs.
Few energy metabolism genes were downregulated by
RSG at any time point (≤3% for both 3T3-L1 and
C3H/10T1/2 adipocytes). However, among the downregu-
lated, 3 were shared by the two adipocyte types: acyl-CoAPPAR Research 5
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Figure 2:Transcriptionalregulationofgenesinvolvedinmitochon-
drial metabolic function. Shown is a heatmap of mean fold changes
of probe set intensities in 3T3-L1 and C3H/10T1/2 adipocytes
treated with RSG compared to DMSO over time (n = 3p e r
time point in each cell type). Each row represents one probe set.
The probe sets were grouped by their functions as indicated, and
arranged in the same order for both cell types. Only fold changes
signiﬁcantly diﬀerent (P<0.0 5 )w e r es h o w ni nc o l o r s( r e do r
green).
synthetase long-chain family member 5 (Acsl5), which acti-
vates exogenous fatty acids destined for triglyceride synthesis
[26], short/branched chain acyl-Coenzyme A dehydrogenase
(Acadsb), and Slc25a24, which encodes a mitochondrial
membrane phosphate carrier.
3.3. RSG Increased Gene Transcripts Encoding Proteins Regu-
lating Mitochondrial Protein Synthesis, Transport and Folding,
and Mitochondrial Structure in Diﬀerentiated 3T3-L1 and
C3H/10T1/2 Adipocytes. Mitochondrial biogenesis involves
both translation of mitochondrial DNA-encoded genes on
mitochondrial ribosomes, and translation of nuclear DNA-
encodedgenesinthecytosol,followedbytranslocationofthe
nascent proteins across the mitochondrial membranes and
properfoldingoftheseproteinswithinmitochondriaassisted
bytranslocasesofinnerandoutermitochondrialmembranes
(TIMMs & TOMMs) and heat shock proteins (HSPs).
As shown in Figure 3(a), of the 137 probe sets represent-
ing mitochondrial HSPs, ribosomal proteins, and TIMMs
& TOMMs, few were aﬀected by RSG at 1, 2, and 4hrs.
However, at 7hrs after RSG treatment, 18% and 23% of the
genes were induced in 3T3-L1 and C3H/10T1/2 adipocytes,
respectively, whereas the rest remained unchanged except for
afew(2%)thatweredownregulated.Thenumberofinduced
genes increased slightly at 24 and 48hrs in both cell types.
RSG also induced mitochondrial structural proteins
not directly involved in metabolic function (Figure 3(b)),
including mitoﬁlin (Immt), optic atrophy 1 (Opa1) at 24
and 48hrs in both 3T3-L1 and C3H/10T1/2adipocytes, and
BCS1-likeprotein(Bcs1l)inC3H/10T1/2at24and48hr,but
unaﬀectedin3T3-L1adipocytes.Surfeit1(Surf1),previously
found to be induced by RSG in db/db adipose tissue but not
in DIO mice [7], was downregulated by RSG in 3T3-L1 and
C3H/101/2 adipocytes at 24 and/or 48hrs.
3.4. RSG Eﬀects on Transcription Factors Regulating Mito-
chondrial Biogenesis. Ligand-bound PPARγ could regulate
the expression of mitochondrial genes by interacting with
transcription factors that act directly at the promoters of
these genes. Alternatively, PPARγ activation could induce or
suppress the expression of nuclear factors that in turn inter-
actwithmitochondrialgenepromoters.Toevaluatethelatter
possibility, RSG eﬀects on the transcription of transcription
factors/cofactors known to regulate mitochondrial gene
expression [27–30] were examined. As shown in Figure 3(c),
PGC-1β (Ppargc1b) was induced at 2 and 4hr in 3T3-L1
and C3H/10T1/2 adipocytes, respectively, and the induction
remained through 48hrs. Meanwhile, PGC-1α (Ppargc1a)
was induced by RSG only at 24hr in both cell types. PPARα
(Ppara) and ERRα (Essra) were both induced by RSG at
24 and 48hr in 3T3-L1 adipocytes, and 7, 24, and 48hr
in C3H/10T1/2 adipocytes. Surprisingly, the transcriptional
corepressor RIP140 (Nrip1) was induced by RSG in both cell
types at 2hrs, and remained induced through 24hrs in 3T3-
L1 adipocytes, but returned to the level comparable to that
in the DMSO-treated after 2hrs in C3H/10T1/2 adipocytes.
There was no eﬀect, or no consistent eﬀect between the two
cell types, on other transcription factors/cofactors, including
nuclear respiratory factor 1 (Nrf1) and 2 (Gabpa and
Gabpb1), PPARγ cofactor-related 1 (Pprc1), mitochondrial
transcription factor A (Tfam), B1 (Tfb1m), B2 (Tfb2m), and
LXRα(Nr1h3),shownrecentlytobecapableofinhibitingthe
brown adipose phenotype [29].
3.5. Validation of Microarray Findings. The transcription of
9 representative genes encoding control point enzymes or
their subunits, including Cpt1b (FAO), Idh3a (TCA cycle),
and Cycs (OXPHOS), as well as citrate synthase (Cs; TCA
cycle), hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-
Coenzyme A thiolase/enoyl-Coenzyme A hydratase, alpha
subunit (Hadha; FAO), Opa1 (structural protein), Cidea,
Ppargc1b,andUcp1wereexaminedbyQRT-PCRusingRNA
from 3T3-L1 and C3H/10T1/2 adipocytes. The results gen-
erally agreed with the microarray data (Table 5 of the Sup-
plementary Material) except that the increase of Ppargc1b
mRNA by RSG in C3H/10T1/2 adipocytes appeared to be
statistically signiﬁcant at 2hr by QRT-PCR but not by
microarray.
To investigate whether the increased mitochondrial gene
transcription was associated with increased mitochondrial
mass, we conducted live mitochondrial staining using Mito
Tracker Red CMXRos in 3T3-L1 adipocytes. RSG increased
mitochondrialstainingareato123%and151%oftheDMSO
control at 24 and 48hrs, respectively (Figures 4(a) and 4(b)).
To conﬁrm the increased mitochondrial staining was
associated with increased mitochondrial metabolic func-
tions, we examined RSG eﬀects on citrate synthase activity
and O2 consumption. RSG signiﬁcantly increased citrate
synthase activity at 24hrs, and continued to increase the6 PPAR Research
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Figure 3: Transcriptional regulation of mitochondrial ribosomal proteins, TIMMs and TOMMs, HSPs (a), structural proteins (b), and
transcription factors (c). Shown is a heatmap of mean fold changes of probe set intensities in 3T3-L1 and C3H/10T1/2 adipocytes treated
with RSG compared to DMSO over time (n = 3 per time point in each cell type). Each row represents one probe set. Certain genes were
represented by morethan one probe set as indicated. Only fold changes signiﬁcantly diﬀerent (P<0.05) were shown in colors (red or green).
activity, reaching 177% of the DMSO control at 48hrs
(Figure 4(c)).
To examine RSG eﬀects on cell respiratory rate, 48hrs
after treatment, 3T3-L1 adipocytes were transferred to O2
Biosensor plates free of RSG, and the decrease of O2
concentrations (leading to increased ﬂuorescence) in the cell
suspension was monitored. The diﬀerence in O2 consump-
tion between RSG- and DMSO-treated adipocytes increased
with time, reaching the maximum (3∼4-folds) 6 hrs after
the transfer (Figure 5(a)). In a separate experiment, 3T3-
L1 adipocytes were treated with increasing concentrations of
RSG for 48hrs, followed by incubation in an O2 biosensor
plate for 6hrs. The RSG-induced O2 consumption was dose
dependent (Figure 5(b)).
3.6. Association of Adiponectin Secretion with Adipose Mito-
chondrial Biogenesis. Adipose mitochondria were recently
shown to be essential in adiponectin production [31]. We
therefore examined the association of adiponectin secretion
and RSG-induced mitochondrial biogenesis in diﬀerentiated
3T3-L1adipocytes.Adiponectinlevelsincreasedwithtimein
the medium from both RSG- and DMSO-treated adipocytesPPAR Research 7
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Figure 4: RSG increased mitochondrial staining and citrate synthase activity in 3T3-L1 adipocytes. (a) Representative pictures of 3T3-L1
adipocytes stained with Mito Tracker Red CMXRos (for mitochondria, red) and Hoechst (for nucleus, blue). Magniﬁcation = 400x. (b)
Quantiﬁcation of mitochondrial staining (n = 8 each treatment). (c) Measurement of citrate synthase activity (n = 2 each condition). All
numerical data were expressed as mean ± S.E. All experiments were repeated at least once.
(Figure 6);however,therewassigniﬁcantlymoreadiponectin
productionfromtheRSG-treatedadipocytesat24and48hrs
compared to the DMSO-treated adipocytes.
4. Discussion
In the current study, the eﬀects of RSG on mitochondrial
gene expression in 3T3-L1 and C3H/10T1/2 adipocytes
were examined in a systematic manner. RSG induced
the transcription of genes encoding proteins regulating
mitochondrial energy metabolism, proteins responsible for
mitochondrial protein synthesis, transport and folding, and
mitochondrial transcription factors in both cell types. The
timing of the changes was consistent with the cascade of
mitochondrial biogenesis, that is, initiated by upregulation
oftranscriptionfactor(s)suchasPGC-1β (startingat2hours
of RSG treatment), followed by increase in the biosynthesis
machinery (7 hours) and then by increase in the functional
components of the organelle (24 hours). Furthermore,
the transcriptional increases by RSG were associated with
increased mitochondrial staining, citrate synthase activity,
and O2 consumption. Our results validated a direct role of
RSG in the stimulation of adipose mitochondrial biogenesis
and function.
The two murine cell types examined were derived from
embryos of diﬀerent mouse strains [32, 33], capable of com-
mitting to diﬀerent cell lineages [14], and were diﬀerentiated
to adipocytes with distinct protocols. While some adipocyte-
related genes, such as adipsin (Adn), fatty acid synthase
(Fasn), glucose transporter 1 (Slc2a1), responded to RSG in
a manner considerably diﬀerent between the two cell types
(Figure 3 of the Supplementary Material), a substantial list
of mitochondrial genes was aﬀected by RSG in a strikingly
similar manner. The results were consistent with previous
ﬁndings in murine [8, 10] and human adipocyte cultures [9]
as well as in adipose tissues [4–7, 34], indicating the eﬀect of
PPARγ activation on mitochondrial biogenesis is prevalent
among adipocytes derived from diﬀerent conditions.
It is of interest that among mitochondrial genes PDK4
was the ﬁrst responding to RSG treatment transcriptionally8 PPAR Research
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Figure 5: RSG increased O2 consumption rate in 3T3-L1
adipocytes. (a) After treatment with RSG (1μM) or DMSO (n = 8
each) for 48hrs, 3T3-L1 adipocytes were transferred to the Oxygen
Biosensor plates, and assayed for O2 c o n s u m p t i o na t0 ,2 ,4 ,6 ,8 ,1 0 ,
and 12hrs after the transfer (see Methods for more details). ∗P<
0.05 versus DMSO at matching time points. (b) After treatment
with RSG (10, 3.3, 1.1, 0.37, 0.12, 0.041, 0.014, 0.0046, 0.0015, and
0.00051μM) or DMSO (n = 3 each condition) for 48hrs, 3T3-
L1 adipocytes were transferred to the Oxygen Biosensor plates and
assayed for O2 consumption 6 hrs after the transfer. All numerical
data were expressed as mean ± S.E. All experiments were repeated
at least once.
(Table 4 of the Supplementary Material). PDK4 inactivates
PDC, which catalyzes the oxidative decarboxylation of pyru-
vate and thus links glycolysis to the energetic and anabolic
functions of the TCA cycle [21]. While PPARγ activation
induced PDK4 mRNA in 3T3-L1 adipocytes and rat adipose
tissues [34, 35], the implication of PDK4 induction in the
tissue has not been substantially explored. In the heart,
liver, and skeletal muscle, PDK4 expression increases with
starvation and high-fat feeding when free fatty acids become
the major energy source, and PDK4 plays an important
role facilitating FAO, using fatty acids for energy production
[36]. In the current study, increased PDK4 transcription by
RSG in adipocytes might, like in the aforementioned tissues,
facilitate catabolizing fatty acids, although cells’ access to
glucose in the medium was not limited. Consistent with this,
proteins facilitating FAO, including Ehhadh, Crat, and Acsl1
(Table 4 of the Supplementary Material), were among the
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Figure 6: RSG induced adiponectin release from 3T3-L1
adipocytes. Cell culture medium was collected at indicated time
points, and adiponectin concentration was measured (n = 4e a c h
condition at each time point). All numerical data were expressed as
mean ± SE. The experiment was repeated at least once.
few that were induced as early as 2hr, along with most of
the other FAO genes that followed at later time points.
The induction of FAO genes (Figure 2), associated with
increased FAO capacity conﬁrmed by increased capability to
consume O2 (Figure 5), took place when the two adipocyte
types had been incubated for more than 24hrs in the
washout medium free of serum and supplementation of
fatty acids. The free fatty acid substrate for oxidation
may have derived from hydrolysis of triglycerides stored in
the adipocytes, because transcription of genes regulating
lipolysis, for example, hormone sensitive lipase (Lipe) and
adipose tissue triglyceride lipase (Pnpla2), was induced by
RSG (Table 4 of the Supplementary Material). Consistent
with this, RSG has been previously shown to induce
lipase transcription and lipolysis in adipocytes and adipose
explants [10, 37].
The increased PGC-1β,P G C - 1 α,E R R α,a n dP P A R α
transcription in 3T3-L1 and C3H/10T1/2 adipocytes was
consistent with previous in vivo ﬁndings that RSG induced
some [8, 9]o ra l l[ 7] of these transcription factors in
adipose tissues from DIO, db/db, ob/ob mice, and T2DM
patients. PGC-1β was one of the earliest induced by RSG
in both adipocyte types, and the induction lasted through
48hrs (Figure 3(c)). PGC-1β overexpression in muscle was
associated with increased mitochondrial biogenesis, O2
consumption, and expression of FAO genes and OXPHOS
electron transporters [38, 39]. While PGC-1β is thought
to be less frequently regulated at the transcriptional level
compared to PGC-1α [40], with which PGC-1β shares a
complementary role [41], Powelka et al. showed RIP140
knockdown in 3T3-L1 adipocytes augmented mitochondrial
biogenesis associated with increased PGC-1β transcription
without changing PGC-1α mRNA level [27]. The current
result indicates PGC-1β may be an immediate target of
PPARγactivationandmayplayapivotalroleinRSG-induced
mitochondrial biogenesis.PPAR Research 9
It is surprising that RIP140, a negative regulator of mito-
chondrialbiogenesis[27,42]andantagonistofPGC-1α[43],
was also among the earliest transcription factors/cofactors
induced by RSG (Figure 3(c)). RIP140 is known to interact
withPPARγ [44],andRIP140transcription increasedduring
adipocyte diﬀerentiation from preadipocytes [27, 45], a
process associated with marked mitochondrial biogenesis
[8]. The relationship between RIP140 transcription and
RSG-induced adipose mitochondrial biogenesis is worth
further investigation.
The induced transcription of a vast number of mito-
chondrial genes by RSG suggests there is general presence
of PPAR-responsive elements (PPREs) in the promoter
regions of these genes. In fact, conﬁrmed PPREs have been
documented for quite a few genes, including some of the
early responsive ones, PDK4, Acsl1, and Ucp3, as well as
others such as Cbt1b, Timm13a, PPARα,a n ds of o r t h[ 24,
46–48]. In silico analysis revealed 143 of the mitochondrial
genes contained at least one exact match with PPRE core
sequence [24] in the promoter regions between +100 and
−2000 base-pairs relative to the transcription start site
(Table 6 of the Supplementary Material). Among the genes,
in addition to most of those mentioned above, were PGC-1β,
ERRα and a number of those involved in energy metabolism
and mitochondrial biogenesis. While the role of the PPREs
needs further validation via other experimental approaches,
their prevalence is consistent with the implication of a
direct role of PPARγ in inducing adipose mitochondrial
biogenesis.
It is intriguing to speculate the physiological rele-
vance of adipose mitochondrial biogenesis. Kaaman et
al. [49] recently showed there was strong association
between mitochondrial DNA copy number and lipogenesis
in human white adipose tissue from obese but other-
wise healthy human volunteers. Lipogenesis needs ATP,
and thus mitochondria, and one way by which adipose
tissue participates in whole-body energy homeostasis is
through lipid storage. Another way that links the tissue
to energy metabolism is through its endocrine function,
that is, secretion of adipokines, particularly adiponectin,
also known as the most abundant secretory protein from
adipocytes [50, 51]. A recent study showed ATP generation
by mitochondria is essential to adiponectin production
in T2DM mice and adipocyte cultures [31]. Consistent
with this, we found RSG induced adiponectin secretion
(Figure 6).
In conclusion, a direct, stimulatory role of RSG on
mitochondrial biogenesis was demonstrated in two com-
mon murine adipocyte models. The time course of the
transcriptional regulation was mapped. PDK4 was the ﬁrst
induced gene, followed by a number of genes facilitating
FAO/TCA/OXPHOS, leading to increased FAO capacity.
PGC-1β wasamongtheﬁrstresponsivetranscriptionfactors,
implying its potentially pivotal role. The eﬀect of RSG on
mitochondrial function was linked to fatty acid metabolism
and adiponectin production in diﬀerentiated adipocytes,
revealing an underexplored mechanism by which PPARγ
improves insulin sensitivity in vivo.
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